Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,129.62
(
0.93%
)
US TECH 100
26,107.60
(
1.30%
)
Dow Jones
49,575.04
(
0.26%
)
Brent Oil
96.54
(
1.61%
)
Bitcoin
78,788.27
(
3.22%
)
News Focus
News Focus
Post# of 257437
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 213674

Monday, 06/24/2019 9:34:13 AM

Monday, June 24, 2019 9:34:13 AM

Post# of 257437
BMY’s CHECKMATE-459 study testing Opdivo-vs-Nexavar in 1L-HCC fails to show statsig OS advantage (HR=0.85; 95% CI=[0.72, 1.02]; p=0.075):

https://finance.yahoo.com/news/bristol-myers-squibb-announces-results-105900314.html

This was a fairly close miss.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today